Cargando…
Particle swarm optimization artificial intelligence technique for gene signature discovery in transcriptomic cohorts
The development of gene signatures is key for delivering personalized medicine, despite only a few signatures being available for use in the clinic for cancer patients. Gene signature discovery tends to revolve around identifying a single signature. However, it has been shown that various highly pre...
Autores principales: | Murphy, Ross G., Gilmore, Alan, Senevirathne, Seedevi, O'Reilly, Paul G., LaBonte Wilson, Melissa, Jain, Suneil, McArt, Darragh G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556859/ https://www.ncbi.nlm.nih.gov/pubmed/36249564 http://dx.doi.org/10.1016/j.csbj.2022.09.033 |
Ejemplares similares
-
Translation of tissue-based artificial intelligence into clinical practice: from discovery to adoption
por: Geaney, Alice, et al.
Publicado: (2023) -
Prostate cancer heterogeneity assessment with multi-regional sampling and alignment-free methods
por: Murphy, Ross G, et al.
Publicado: (2020) -
Identification of Candidate Small-Molecule Therapeutics to Cancer by Gene-Signature Perturbation in Connectivity Mapping
por: McArt, Darragh G., et al.
Publicado: (2011) -
KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies
por: Wen, Qing, et al.
Publicado: (2016) -
Evolutionary genetic algorithm identifies IL2RB as a potential predictive biomarker for immune-checkpoint therapy in colorectal cancer
por: Alderdice, Matthew, et al.
Publicado: (2021)